A former study (submitted) in 32 severely asphyxiated infants participating in a randomized
double blind study, in which early postnatal allopurinol or a placebo (within 4 hours after
birth) was administered to reduce free radical formation and consequently
reperfusion/reoxygenation injury to the newborn brain, showed an unaltered high mortality and
no clinically relevant improvement in morbidity in infants treated with allopurinol. It was
hypothesized that postnatal allopurinol treatment started too late to reduce
reperfusion-induced free radical surge and that initiating allopurinol treatment of the fetus
with (imminent) hypoxia already via the mother during labor will be more effective to reduce
free radical-induced post-asphyxial brain damage.
Phase:
Phase 3
Details
Lead Sponsor:
UMC Utrecht
Collaborator:
ZonMw: The Netherlands Organisation for Health Research and Development